Leukaemia Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been newly diagnosed with acute myeloid leukaemia (AML)
• People whose AML has been classified as "adverse-risk" based on a standard medical scoring system called ELN 2022 criteria (confirm with trial site)
• People who were between 16 and 65 years old at the time of their AML diagnosis
• People whose leukaemia went into complete remission (no detectable cancer) after 1 or 2 rounds of initial chemotherapy treatment
• People who are largely able to carry out normal daily activities, with little to no physical limitation (rated 0 or 1 on a standard medical scale)
• People who are willing and able to give written consent to participate, or whose legal guardian is able to do so on their behalf

Who may not be able to join:

• People whose AML has been classified as "favourable-risk" or "intermediate-risk" under the ELN 2022 criteria, rather than adverse-risk
• People who were younger than 16 or older than 65 at the time of their AML diagnosis
• People whose leukaemia only went into remission after 3 or more rounds of chemotherapy, or whose leukaemia did not go into remission at all
• People who have significant physical limitations affecting daily activity (rated 2 or higher on the standard medical scale)
• People who have other serious illnesses or mental health conditions that could affect their safety, ability to follow the study plan, attend follow-up visits, or give informed consent

Important: Always verify eligibility with the trial site directly before applying.